Lori J Braender insider trades: Aquestive Therapeutics (AQST) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Lori reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | AQST | ↓ Sell | 40,102 | $4.17 | $167K | Direct | Mar 11, 2026 (1d) |
| Jun 8, 2022 | AQST | ↑ Buy | 13,761 | $0.96 | $13K | Direct | Jun 10, 2022 (2d) |
| Mar 16, 2020 | AQST | ↑ Buy | 14,000 | $1.54 | $22K | Direct | Mar 18, 2020 (2d) |
| Aug 9, 2019 | AQST | ↑ Buy | 10,000 | $4.07 | $41K | Direct | Aug 13, 2019 (4d) |
| Nov 27, 2018 | AQST | ↑ Buy | 1,000 | $10.57 | $11K | Direct | Nov 29, 2018 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other AQST insiders
Open-market trades in the last 12 months
About Lori J Braender's insider trades
Lori J Braender is Corporate Secretary at Aquestive Therapeutics (AQST). Since Nov 27, 2018, Lori has reported 4 open-market purchases worth $86K and 1 sale worth $167K on SEC Form 4. In the last 12 months: 1 sale ($167K).
Their filings also include grants and awards (13 filings), shares withheld for taxes (4 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AQST insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.